These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26316205)

  • 1. Impact of nephrolithiasis on kidney function.
    Sigurjonsdottir VK; Runolfsdottir HL; Indridason OS; Palsson R; Edvardsson VO
    BMC Nephrol; 2015 Aug; 16():149. PubMed ID: 26316205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
    Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
    Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of stone size to chronic kidney disease in kidney stone formers.
    Ahmadi F; Etemadi SM; Lessan-Pezeshki M; Mahdavi-Mazdeh M; Ayati M; Mir A; Yazdi HR
    Int J Urol; 2015 Jan; 22(1):104-8. PubMed ID: 25168662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes and consequences of kidney loss in patients with nephrolithiasis.
    Worcester E; Parks JH; Josephson MA; Thisted RA; Coe FL
    Kidney Int; 2003 Dec; 64(6):2204-13. PubMed ID: 14633144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
    Kittanamongkolchai W; Mara KC; Mehta RA; Vaughan LE; Denic A; Knoedler JJ; Enders FT; Lieske JC; Rule AD
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):476-482. PubMed ID: 28148559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III.
    Gillen DL; Worcester EM; Coe FL
    Kidney Int; 2005 Feb; 67(2):685-90. PubMed ID: 15673317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease.
    Domingos F; Serra A
    Nephrol Dial Transplant; 2011 Mar; 26(3):864-8. PubMed ID: 20709737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
    Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD
    Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study.
    Eisner BH; Iqbal A; Namasivayam S; Catalano O; Kambadakone A; Dretler SP; Sahani DV
    J Endourol; 2008 Oct; 22(10):2207-10. PubMed ID: 18831676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome.
    Rendina D; De Filippo G; Zampa G; Muscariello R; Mossetti G; Strazzullo P
    Nephrol Dial Transplant; 2011 Jul; 26(7):2256-63. PubMed ID: 21051502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrolithiasis and loss of kidney function.
    Keddis MT; Rule AD
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):390-6. PubMed ID: 23736840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography.
    Shimizu T; Kitada H; Umeyama M; Hori H; Takasaki N
    J Urol; 2013 May; 189(5):1747-52. PubMed ID: 23159585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study.
    Chuang TF; Hung HC; Li SF; Lee MW; Pai JY; Hung CT
    BMC Nephrol; 2020 Jul; 21(1):292. PubMed ID: 32698782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
    Viktorsdottir O; Palsson R; Andresdottir MB; Aspelund T; Gudnason V; Indridason OS
    Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and chronic kidney disease.
    Belarbia A; Nouira S; Sahtout W; Guedri Y; Achour A
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):931-40. PubMed ID: 26354564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Jun; 183(6):2244-8. PubMed ID: 20400141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers.
    Choy SH; Nyanatay SA; Sothilingam S; Malek R; J R S; Toh CC; Sundram M; Md Yusoff NA; Nagappan P; Kamaruzaman S; Yeoh WS; Ong TA; Lim J
    PLoS One; 2022; 17(4):e0265510. PubMed ID: 35421118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.